TreeAge Pro > 공학용

본문 바로가기

회원메뉴

쇼핑몰 검색

회원로그인

오늘 본 상품

  • TreeAge Pro
    TreeAge Pr
    0
TreeAge Pro > 공학용
리뷰 0 위시 1

TreeAge Pro 요약정보 및 구매

상품 선택옵션 1 개, 추가옵션 0 개

개발사 TreeAge Software
판매가격 0원
포인트 0점
배송비결제 주문시 결제

선택옵션

선택된 옵션

위시리스트

관련상품

등록된 상품이 없습니다.

상품 정보

상품 상세설명

Visual Modeling Tool

With the visual Tree Diagram Editor, you can easily create model structure to represent the problem being studied. The model structure will include decision points and all events that could occur. Different node types within the structure reflect whether branches are alterative options or possible events.

Insert nodes anywhere within the model structure. Copy or move individual nodes or subtrees within the model. Clone repeating sections of the model to reduce modeling time and ensure consistency within the model.

In the model below, there is a single decision, whether to litigate or accept a settlement offer. There are also points were the outcome is unknown (win/lose case and damage amounts), represented by circles. Finally, there are terminal nodes which reflect the overall value of each scenario, represented by triangles.
Simple Legal Tree



Evaluate and Compare Strategies
Once the model is complete, TreeAge Pro automatically generates the algorithms required to evaluate the model and choose the optimal strategy. This allows you to focus on the problem at hand and not the calculations needed to evaluate the model.

Standard algorithms give weight to each possible outcome within the strategy based on its probability. The combined weighted average generates an overall expected value for each strategy.

Analyses can choose the optimal strategy based on a comparison of all options. Tree preferences control the method of comparison from among these choices – maximum, minimum, cost-benefit, multi-attribute or cost-effectiveness (requires Healthcare Module). Models can also store multiple metrics for value. Then, simply change the active metric and reanalyze the same model.

When the model from above is analyzed using Roll Back, expected values (EVs) are calculated at all nodes. At the decision node, the maximum value is selected as the optimal strategy.


Legal Tree Rolled Back



Study Uncertainty
TreeAge Pro allows you to study how uncertainty in a model’s inputs affect the conclusions we can draw via its outputs. In order to study uncertainty of an individual parameter, the parameter must be represented by a variable. The variable then can be analyzed over a range of uncertainty rather than using a single point estimate.
The model below evaluates to the same values as the earlier models, but three independent parameters are defined using variables. Those variables are then referenced within the model in probability and value expressions.

Legal Tree with Variables
Legal Tree with Variables


Now the model can be evaluated using sensitivity analysis to study uncertainty. For example, the following analysis uses a range for the pWin variable from 0.5 to 0.7 with four intervals. This analysis reevaluates the model at pWin values 0.5, 0.55, 0.6, 0.65 and 0.7, then shows the EV of each strategy based on the parameter range.

Sensitivity Analysis on Legal Tree
Sensitivity Analysis on Legal Tree

The graph above identifies a threshold at the pWin value of 0.55.

If pWin is less than 0.55, then the Settlement Offer EV is higher.
If pWin is greater than 0.55, then the Litigate EV is higher.




Healthcare Models
With the Healthcare Module, you can create trees that are evaluated on the basis of cost-effectiveness, as well as either cost or effectiveness as a single measure.

Healthcare models usually begin with a decision node with a branch for each treatment option for a specific health condition. The subtree for each treatment option follows the condition through treatment, including any number of possible outcomes.

The model presented below includes two strategies for treating a specific tumor. Each strategy has a different likelihood of eradicating the tumor. At each terminal node, a values for cost and effectiveness associated with that outcome.

Simple Healthcare Tree






Cost-Effectiveness Analysis
Once the model is complete, TreeAge Pro automatically generates the algorithms required to evaluate the model and choose the optimal strategy. This allows you to focus on the problem at hand and not the calculations needed to evaluate the model.

Standard algorithms give weight to each possible outcome within the strategy based on its probability. The combined weighted average generates an overall expected value for each strategy.

TreeAge Pro’s Healthcare Module allows you to compare strategies on the basis of cost-effectiveness via incremental cost-effectiveness ratios and/or net benefits. You can also compare strategies in the same model based solely on cost or comparative effectiveness (CER). You can even use non-standard measurements such as infections, deaths, etc.

The following model compares two treatments for a tumor.

Simple Healthcare Tree
Simple Healthcare Tree

Cost-effectiveness analysis compares the strategies based on a CE frontier.

Cost-Effectiveness Graph
Cost-Effectiveness Graph

If there were dominated strategies in this model, they would be presented above and to the left of the CE frontier.

The Rankings report shows the numeric calculations comparing the strategies, including the incremental cost-effectiveness ratio (ICER).

Cost-Effectiveness Rankings


The ICER can then be compared to a willingness-to-pay (WTP) threshold to determine whether we can afford the more effective treatment on the basis of cost-effectiveness.

Healthcare decision trees are normally much more complicated and often include a Markov model for each treatment option. More complex healthcare trees may have many Markov models included in each strategy.

Healthcare models can also incorporate heterogeneity and event tracking as described in a separate feature description on this page.






Study Uncertainty on Healthcare Models
TreeAge Pro allows you to study how uncertainty in a model’s inputs affect the conclusions we can draw via its outputs. TreeAge Pro supports two ways to study uncertainty:


 - Probabilistic sensitivity analysis
 - The Healthcare Module extends the two types of sensitivity analysis to compare strategies via cost-effectiveness analysis.

Deterministic sensitivity analysis In order to study uncertainty individual parameters over a value range. The most common form of deterministic sensitivity analysis studies a single parameter via 1-way sensitivity analysis. 2-way, 3-way and tornado diagrams are also supported.

In order to run 1-way sensitivity analysis on a model, the parameter must be represented by a variable. The variable then can be analyzed over a range of uncertainty rather than using a single point estimate. Consider the model below.

Simple Healthcare Tree


Simple Healthcare Tree

Perhaps we are concerned about the probability of eradicating the tumor with the new treatment – surgery and radiation. We can run 1-way sensitivity analysis on the variable pEradicateRadSurg for a range of 0.5 to 0.9 with 4 intervals. This will recalculate the model five times for values 0.5, 0.6, 0.7, 0.8, 0.9.

CE Sensitivity Analysis


CE Sensitivity Analysis

Using secondary outputs, the five sets of results can be used to review the strategy comparison on the basis of cost-effectiveness, cost or effectiveness. The comparison based on effectiveness-only is shown below. This graph generates a threshold of 0.6, above which the new treatment is more effective.

CE Sensitivity Analysis - Effectiveness Graph


CE Sensitivity Analysis - Effectiveness Graph

The comparison based on cost-effectiveness, using Net Monetary Benefits calculations using a WTP of $50K/LY is shown below. This graph generates a threshold of 0.749, above which the new treatment is more cost-effective (given the WTP assumption).


CE Sensitivity Analysis - Net Benefits Graph


CE Sensitivity Analysis - Net Benefits Graph

Probabilistic sensitivity analysis (PSA) studies the combined effect of multiple uncertainties upon your model.

To perform PSA, one or more parameters must be represented by distributions. The distributions are then sampled, substituting the sampled values into the model and recalculating the EVs. Repeating this many times provide creates a large set of expected values (EVs), each reflecting a different set of sampled parameters.

Within the overall result set, some sets of EVs will confirm the base case analysis, while others will not. This provides an overall measure of certainty for the base case conclusions.

The model above was modified to include three parameter distributions:

Probability of eradicating the tumor with radiation only.
Probability of eradicating the tumor with radiation and surgery.
Cost of surgery.
A PSA Monte Carlo simulation was run to generate 1000 separate result sets from 1000 sets of parameter samples. The simulation results can then be parsed to find ranges and confidence intervals for all outputs (including ICER) and other secondary outputs that measure the level of certainty in the base case analysis – that the new treatment was most cost-effective given WTP $50K/LY.

The following ICE scatterplot graph shows simulation iterations plotted for incremental cost and incremental effectiveness. The plots below and to the right of the WTP line confirm the base case analysis.

CE PSA - ICE Scatterplot
CE PSA - ICE Scatterplot

The following Acceptability Curve shows the percentage of simulation iterations that consider each strategy the most cost-effective over a range of WTP.

CE PSA - Acceptability Curve
CE PSA - Acceptability Curve

There are many other output graphs and numeric reports available from the simulation results.



State Transition/Markov Models
Often, healthcare models need to follow a disease process into the future. The most common approach to this issue is to create a state transition or Markov model.

TreeAge Pro supports Markov models through the decision tree structure. Note the model below.

Markov Model 

Markov Model: A Markov model consists of the Markov node and everything to its right. A decision tree model can contain many Markov models for specific strategies, subgroups, etc. Each Markov model is evaluated as a unit, generating an expected value that can feed back into the analysis results for the entire decision tree.

Health States: The direct branches of the Markov node are the health states. The cohort starts each cycle distributed among the health states.

Transition Subtrees: Each health state has its own transition subtree, which specifies the events that can occur within a cycle. At each point where the transition subtree terminates, the cohort is returned to one of the states to begin the next cycle. This results in a different distribution of the cohort among the health states to start each cycle.

Accumulating Value: As the cohort cycles through the health states and transition subtrees, cost, effectiveness and/or other value measures are accumulated, both based on the starting health state and on the events that occur within the cycle.

Expected Value: After all cycles are complete, the overall accumulated cost and/or effectiveness generates the expected value (EV) for the Markov model in its entirety. This accounts for all combinations of events over any number of cycles. The overall Markov model EV can then be fed upstream into an overall evaluation of treatment options for a disease.




Evaluating Markov Models
When Markov models are evaluated, they eventually provide a single expected value (EV) for each active payoff (frequently cost and/or effectiveness). However, you may want to see further into the individual calculations that result in the overall EV. Markov Cohort Analysis provides this detail.

Consider the following model.

Markov Model

Markov Model

Markov Cohort Analysis provides the cycle by cycle accumulation of value from each state and transition.

Markov Cohort Analysis


Markov Cohort Analysis

Review of these transitions and calculations is a valuable tool in verifying whether your model is working as designed. For this cost-effectiveness model, the overall accumulated cost and effectiveness values after the last cycle become the overall EV for the Markov model.

Markov cohort analysis also provides access to graphs showing the distribution of the cohort among the states by cycle and the accumulation of value by cycle. One such graph is the survival curve shown below.

Markov Survival Curve





Heterogeneity and Event Tracking
TreeAge Pro allows you to extend beyond the traditional limitations of expected value and/or Markov models. By running individual “trials” through the model by random walk (microsimulation), you can introduce heterogeneity and event tracking into your model.

Heterogeneity
When individuals are run through the model, you can assign different characteristics to those individuals to create a heterogeneous cohort. For example, each individual trial could have its own age, gender, ethnicity, weight, tumor type, disease stage, etc. Each such characteristic can be referenced within the model to calculate probabilities, cost, utility, etc.

TreeAge Pro distributions can be sampled for each trial to generate a characteristic for that trial. You can also load known patient data into the model and use that data for a trial within the model.

Event Tracking
TreeAge Pro trackers can be used to record events and other characteristics that change as a trial runs through the model. Unlike variables, which apply to the entire cohort, trackers store and retrieve data specific to each trial.

For example, you might have a stroke event in your model. Without microsimulation, the stroke event could only impact that specific cycle. However, with microsimulation, you can record (or count) the stroke event in a tracker. Then you can check the value of the tracker in all subsequent cycles, likely to drive worse transition probabilities and/or utilities after a stroke.

Example
The attached model demonstrates both techniques (click for larger image).

Microsimulation Model 


The model includes two distributions to generate heterogeneity, one for starting age and one for tumor type. The properties of the age distribution are displayed below.


Age Distribution
Age Distribution


Before each trial is run through the model, a sample is drawn to generate a starting age between 30 and 50. The trial’s age for each cycle is then incremented within the Markov model based upon the starting age and the cycle number. The current age is then use for background mortality checks.

The model also tracks strokes via an event within the Metastases state’s transition subtree. See below.

Microsimulation - Update Tracker
Microsimulation - Update Tracker

When a trial reaches the node Stroke, the tracker t_strokes is incremented by one. The probability variable definition for pMetastasesToDead increases the probability of death in future cycles based on the number of strokes via the t_stroke tracker as follows.

pMetastasesToDead = tDeathMetastases[t_strokes]
This expression pulls a different probability value from the table based on the number of strokes the trial has had. 




Discrete Event Simulation
TreeAge Pro supports Discrete Event Simulation (DES) or Time-to-Event Models within the decision tree format. DES and Time node types facilitate a time-based approach to models.

DES Tree
DES/Time-to-Event Model

While Markov models use fixed cycle lengths and probabilities for events, DES models rely on times associated with competing events. The times are drawn from distributions and the shortest time event drives patient flow through the model. Values (cost, effectiveness) are accumulated based on the time to the next event as well as fixed values associated with specific events.

DES models are analyzed via Microsimulation (individual-patient simulation) and use existing report and graphical outputs. 

사용후기

등록된 사용후기

사용후기가 없습니다.

상품문의

등록된 상품문의

상품문의가 없습니다.

배송정보

License제품 : 3일이내 배송.
국내개발사 제품 : 3 - 4일이내 배송.
외산 수입제품 : 7 - 14일이내 배송.
정확한 배송일자는 제품마다 약간의 차이가 있을 수 있으므로 주문전에 별도문의 확인해 주시기 바랍니다. 

교환/반품

배송이 완료된 상품은 아래에 설명된 예외상황외에는 절대로 반품이 불가합니다.

배송된 상품이 주문내용과 상이하거나 당사 쇼핑몰에서 제공한 정보와 상이할 경우 배송된 상품이 파손,
손상되었거나 오염되었을 경우(단, 구매자 귀책시 제외)
라이센스 제품 (즉 사용자 증서가 이미 발급된 경우) 는 절대 반품이 불가합니다.

패키지 제품의 경우에도 이미
개봉된 제품의 경우 소프트웨어의 특성상 반품 또는 환불이 불가합니다.


상품의 품절 또는 재고 부족 등 위에서 설명한 예외적인 특별한 사유로 상품을 제공할 수 없을 때에는 지체
없이 그 사유를 이용자에게 통지하고 사전에 상품대금을 받은 경우 대금을 받은 날부터 3일 이내에 환불을
위한 조치를 취하고 그렇지 않은 경우 그 사유 발생일로 부터 3일 이내에 계약해제 및 환급조치를 취합니다.

반품 및 교환 문의는 고객지원센터(02-3272-8565)나 메일로 문의 하여 주시기 바랍니다
회사명 (주)코리안소프트플라자
주소 서울 마포구 큰우물로 75 성지빌딩 1210호
사업자 등록번호 105-86-50357 대표 신재욱 전화 02-3272-8565 팩스 02-3272-8565
통신판매업신고번호 제 2014-서울마포-1325호 개인정보 보호책임자 (주)코리안소프트플라자
Copyright © KoreanSoft lnc. All Rights Reserved.